PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 169 filers reported holding PRECIGEN INC in Q1 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $949,739 | +23.5% | 668,830 | 0.0% | 0.04% | +24.1% |
| Q2 2023 | $769,155 | +8.5% | 668,830 | 0.0% | 0.03% | +3.6% |
| Q1 2023 | $708,960 | -50.0% | 668,830 | 0.0% | 0.03% | -68.2% |
| Q3 2022 | $1,418,000 | +58.3% | 668,830 | 0.0% | 0.09% | +54.4% |
| Q2 2022 | $896,000 | -36.5% | 668,830 | 0.0% | 0.06% | -36.0% |
| Q1 2022 | $1,411,000 | -57.7% | 668,830 | 0.0% | 0.09% | -69.7% |
| Q3 2021 | $3,337,000 | -23.5% | 668,830 | 0.0% | 0.29% | -9.8% |
| Q2 2021 | $4,361,000 | -5.4% | 668,830 | 0.0% | 0.33% | -3.8% |
| Q1 2021 | $4,608,000 | +1.3% | 668,830 | +50.0% | 0.34% | +4.6% |
| Q4 2020 | $4,548,000 | +94.3% | 445,930 | -33.3% | 0.32% | +90.6% |
| Q3 2020 | $2,341,000 | -29.8% | 668,830 | 0.0% | 0.17% | -9.6% |
| Q2 2020 | $3,337,000 | +46.7% | 668,830 | 0.0% | 0.19% | +46.9% |
| Q1 2020 | $2,274,000 | – | 668,830 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |